Following an Oak grant of GBP 25 million, The Royal Marsden, based in London, the United Kingdom, will soon begin constructing a state-of-the-art research and clinical care centre on its Sutton site in Outer London. This centre will house over 300 researchers under the same roof as patients, increasing opportunities for collaboration and putting patients at the heart of research into new treatments. It will also expand The Royal Marsden’s capacity and, using the latest and best possible technology, the Centre will provide patients with earlier and faster diagnosis as well as modern and peaceful environments.
“This will make an enormous difference in our ability to improve the diagnosis and treatment of patients, and ultimately, improve survival rates for cancer patients globally,” says Cally Palmer, chief executive of The Royal Marsden.
“I think a unique aspect of this building is that it co-locates truly world-class clinical researchers in the same building that patients are receiving treatment in,” consultant medical oncologist Dr Naureen Starling says. “We think this is going to be really important … to help accelerate novel treatments and breakthroughs into the clinic for patient benefit.”
The Royal Marsden, together with its academic partner The Institute of Cancer Research, London (ICR) is the largest and most comprehensive cancer centre in Europe. It is a centre of excellence with an international reputation for ground-breaking research and pioneering the very latest in cancer treatments and technologies.